DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

Referenz

O’Rourke DM, Nasrallah MP, Desai A. et al.
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma.

Sci Transl Med 2017;
9: eaaa0984

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: